(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VV

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

VV

ST13

US500000086860138

Class

5, 42

Filing

86860138

Registration

6019120

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

07/09/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

12/29/2015

Registration date

03/24/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/08/2026

Last transaction

07/09/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/19/2019

First use in commerce

12/19/2019

Drawing code

5

Owner type

03

Owner location

Cambridge, MA, US

Examiner

CARLYLE, SHAUNIA P

Current location

Historical data usage

Mark description

The mark consists of a stylized letter "V" with an upside down stylized letter "V" behind it.

Holders and representatives

Holders

Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc.

Representatives

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biopharmaceutical agentsmicrobiologicsimmunotherapeuticsother therapeutic agentsfor the prevention and treatment of human diseasesinfectious diseaseautoimmune diseaseinflammatory diseaseimmune disordersallergic disorderscancerimmuno-oncologymetabolic disordersdigestive disordersneurological disorderscardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use; Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; biological preparations in the nature of cultures of microorganisms for medical purposes; Cultures and preparations of microorganisms for medical and veterinary purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; Therapeutic agents in the nature of microorganisms for medical use; nutritional food additives for medical purposes in the nature of microorganisms; dietary supplements; beverages for medical purposes; nutritional food bars for meal replacement and medical purposes

Class 42

Research and development of microbiologicsimmunotherapeuticsother therapeutic agents; Development of pharmaceuticalsdiagnosticsfood additivesdietary supplementsmedical foodsfoods for special dietary use; Scientific research and development services relating to foods and dietary supplements; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto

Publications

History of USPTO decisions and trademark events.

46 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/08/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/08/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/08/2026

E815

TEAS SECTION 8 & 15 RECEIVED

03/13/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/24/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/20/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/19/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/30/2020

IUAF

USE AMENDMENT FILED

01/28/2020

EISU

TEAS STATEMENT OF USE RECEIVED

01/28/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/09/2019

EX5G

SOU EXTENSION 5 GRANTED

08/08/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/08/2019

EXT5

SOU EXTENSION 5 FILED

08/06/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/06/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/07/2019

EX4G

SOU EXTENSION 4 GRANTED

02/05/2019

EXT4

SOU EXTENSION 4 FILED

02/05/2019

EEXT

SOU TEAS EXTENSION RECEIVED

02/05/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/08/2018

EX3G

SOU EXTENSION 3 GRANTED

08/06/2018

EXT3

SOU EXTENSION 3 FILED

08/06/2018

EEXT

SOU TEAS EXTENSION RECEIVED

08/06/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/07/2018

EX2G

SOU EXTENSION 2 GRANTED

02/05/2018

EXT2

SOU EXTENSION 2 FILED

02/05/2018

EEXT

SOU TEAS EXTENSION RECEIVED

02/05/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/08/2017

EX1G

SOU EXTENSION 1 GRANTED

08/04/2017

EXT1

SOU EXTENSION 1 FILED

08/04/2017

EEXT

SOU TEAS EXTENSION RECEIVED

08/04/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/07/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/13/2016

PUBO

PUBLISHED FOR OPPOSITION

12/13/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/23/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/02/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/12/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/11/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/11/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/19/2016

GNRT

NON-FINAL ACTION E-MAILED

04/19/2016

CNRT

NON-FINAL ACTION WRITTEN

04/19/2016

DOCK

ASSIGNED TO EXAMINER

04/15/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/07/2016

NWAP

NEW APPLICATION ENTERED

01/01/2016

Continuous trademark protection

Get notified about every new filing that threatens VV or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.